What a fixed-scope diagnosis actually buys you

Open-ended engagements have a quiet incentive problem. The longer they run, the more they bill, so the pull is always toward more scope and more time. A fixed price with a fixed timeline removes that pull. The provider is paid the same whether the answer takes the full window or arrives early, which changes what the engagement is optimized to produce. What you buy with fixed scope is a clear answer, and a strong reason for everyone to reach it fast.

Fixed scope forces a real decision

A founder who runs an AI data-security company explained why he prefers to buy this way. An open engagement can drift, he said, because the drift is profitable for the other side and comfortable for yours. A fixed box forces a decision. You have two weeks and a set fee, so the work bends toward the questions that actually determine the outcome instead of wandering into interesting side quests. The constraint is doing you a favor. It keeps the engagement pointed at the thing you paid to learn.

He also valued the honesty a fixed scope enables. When the fee does not grow with the recommendation, “do not build this yet” costs the provider nothing to say. In an open engagement that same sentence ends a revenue stream, so it tends to go unsaid. Vendor-led builds reach production about 67% of the time against roughly a third for internal-only efforts, and part of that gap is a provider willing to tell you early when the answer is no.

The deliverable is a decision, not a demo

A director of engineering at a messaging startup described what she actually wanted from a short engagement. Not code. A decision she could take to her leadership with evidence behind it. Can this reach production, what would it cost, what has to be true first, and is it worth doing at all. A fixed-scope diagnosis is built to answer exactly those, because there is no time or budget to build the thing itself, only to determine whether the thing should be built.

That constraint turns out to be a feature. Real AI costs run two to four times the first estimate, and a fixed look at feasibility is how you catch that gap before you are committed to it. The look is cheap. The build it might redirect or cancel is not.

A fixed-scope diagnosis, done honestly, leaves you holding a few concrete things:

A feasibility verdict, whether the feature can reach production or hits a wall first.
A cost read, a grounded estimate instead of the optimistic number from the demo.
A list of preconditions, what has to be true about data, access, and compliance before you build.
A go or no-go you can defend, a decision with evidence, ready to take to whoever holds the budget.

None of that requires a line of production code. All of it requires someone with no incentive to keep the meter running.

How we approach it at Density Labs

This is precisely why the AI Opportunity Assessment is priced and scoped the way it is: two weeks, $2,500, fixed. The number does not move with our recommendation, so we are free to tell you the feature is not ready, or not worth it, when that is the honest read. What you walk away with is a decision you can act on and defend, arrived at before the build budget is committed rather than after it is spent. The fixed box is what makes the honesty possible.

A fixed-scope diagnosis is not a small build. It is a clear answer with the incentives set so that answer can be the truth.